|
|
 |
| |
|
Home > Drug Companies > Dey
Dey
Founded in 1978 and based in Napa, California, DEY has a long history of providing high-quality generic drug products, and has enjoyed significant growth in sales, manufacturing capacity and personnel. Over time, DEY has expanded its product portfolio to include branded products, such as DuoNeb, EpiPen and AccuNeb, which now account for the majority of total company sales.
Dey, L.P. develops, manufactures, and markets innovative airway and allergy medications that save and improve lives. The Company puts patients first through integrated healthcare delivery solutions, and facilitates efficient, cost-effective partnerships with its customers. Dey is committed to investing in its employees and the communities in which they live.
Dey markets its products in the United States through its dedicated sales force that sells to office-based physicians, hospitals and distribution chain organizations. Dey markets its products outside the United States through a network of distributors, some of which are affiliates. Dey Core Competencies include leadership in the respiratory nebulized market, demonstrated ability to successfully market branded products, proven ability to understand market needs, specialty focused experienced sales force, quality reputation, ability to develop combination formulations and intellectual property, state of the art unit-dose manufacturing, seasoned management team.
Dey has grown rapidly in the past decade. Annual net sales and the employee base have tripled since 1993. The company's manufacturing facilities in Napa have been enlarged from 30,000 square feet to more than 300,000 square feet. Dey is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases such as Chronic Obstructive Pulmonary Disease and Asthma and respiratory related allergies such as Anaphylaxis.
Dey is a leader in the development of unit dose oral inhalation products for nebulization. Oral inhalation products are aqueous-based solutions or suspensions that are aerosolized for lung delivery using devices called nebulizers. Pharmaceutical Development scientists at Dey work at the forefront of this technology to develop new products for respiratory conditions. They develop formulation compositions and container closure systems.
At Dey, they are constantly looking for motivated, enthusiastic people whose unique professional talent will enhance their corporate team. Since 1993, the number of their employees has more than tripled, to more than 1000. They develop, manufacture and market innovative airway therapies and allergy drug products. Their work improves quality of life and saves lives. They especially value patients, customers, employees, and the environment in which they work and live.
Back to Drug Companies
|
|
|
|
|
|
|
|